Skip to main content
Other
Insuring Against Losses from Transgenic Contamination: The Case of Pharmaceutical Maize
CARD Working Papers
  • David Ripplinger, North Dakota State University
  • Dermot J. Hayes, Iowa State University
  • A. Susana Goggi, Iowa State University
  • Kendall R. Lamkey, Iowa State University
Publication Date
6-1-2008
Series Number
08-WP 470
Abstract
Concerns about the risk of food supply contamination and the resulting financial losses have limited the development and commercialization of certain pharmaceutical plants. This article develops an insurance pricing model that helps translate these concerns into a cost-benefit analysis. The model first estimates the physical dispersal of maize pollen subject to a number of weather parameters. This distribution is then validated with the limited amount of currently available field trial data. The physical distribution is then used to calculate the premium for a fair-valued insurance policy that would fund the destruction of possibly contaminated fields. The flexible framework can be readily adapted to other crops, management practices, and regions.
Citation Information
David Ripplinger, Dermot J. Hayes, A. Susana Goggi and Kendall R. Lamkey. "Insuring Against Losses from Transgenic Contamination: The Case of Pharmaceutical Maize" (2008)
Available at: http://works.bepress.com/dermot_hayes/59/